ANJAC Health & Beauty Acquires Pillar5 Pharma

Ampersand Capital Partners Acquires Purna Pharmaceuticals

February 12, 2026

Pharmaceuticals

Ampersand Capital Partners acquired Purna Pharmaceuticals, a Belgian contract development and manufacturing provider of liquid and semi-solid pharmaceutical dosage forms. The investment positions Purna to collaborate with Ampersand portfolio company MedPharm to create a trans‑Atlantic topical and transdermal development and manufacturing offering; Creafund, Purna's prior investor, supported the company for more than a decade and was referenced in the transaction announcement.

Jabil Acquires Pharmaceutics International (Pii)

February 6, 2025

Pharmaceuticals

Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.

3Pillar Global Acquires Jonah Group

September 13, 2022

Software

3Pillar Global has acquired Canada-based software engineering firm Jonah Group, adding more than 160 employees and strengthening 3Pillar's engineering capabilities and presence in Toronto's financial technology district. The acquisition expands 3Pillar's capabilities in the banking, financial services and insurance (BFSI) sector and increases its North American footprint.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PCI Pharma Services Acquires Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services has completed the acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO previously owned by Ajinomoto Co., Inc. The deal expands PCI’s US sterile manufacturing footprint in San Diego—adding prefilled syringe and cartridge aseptic capabilities, lyophilization and high-potent vial filling (including ADC support)—and is part of a multi-year, roughly $1 billion investment strategy to broaden advanced drug delivery and fill‑finish capacity.

Water Street Healthcare Partners Acquires Pillr Health from Renovus Capital Partners

January 20, 2026

Healthcare Services

Water Street Healthcare Partners has acquired Pillr Health from Renovus Capital Partners, marking a full exit for Renovus after a seven-year transformation of the business into a scaled, technology-enabled pharmacy optimization platform. Pillr Health will remain led by its existing management team and is expected to expand under Water Street’s healthcare-focused platform build strategy; financial terms were not disclosed.